WuXi Biologics and Toregem BioPharma to advance tooth regeneration treatment
WuXi Biologics (“WuXi Bio”), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a strategic partnership with Toregem BioPharma, a biotech startup emerging from Kyoto University. This collaboration is set to accelerate the development of TRG035, a promising monoclonal antibody targeting USAG-1 for the treatment of congenital adentia, commonly known as tooth […]